PubMed:12626384 / 234-411 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/12626384","sourcedb":"PubMed","sourceid":"12626384","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/12626384","text":"Two recombinant protein therapeutics, Fabrazyme (agalsidase beta) and Replagal (agalsidase alfa), have been approved in Europe as enzyme replacement therapies for Fabry disease.","tracks":[{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":177},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":177},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T3","pred":"source","obj":"sentences"},{"subj":"T3","pred":"source","obj":"sentences"}]},{"project":"GlycoBiology-FMA","denotations":[{"id":"_T7","span":{"begin":16,"end":23},"obj":"FMAID:67257"},{"id":"_T8","span":{"begin":16,"end":23},"obj":"FMAID:165447"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"attributes":[{"subj":"_T7","pred":"source","obj":"GlycoBiology-FMA"},{"subj":"_T8","pred":"source","obj":"GlycoBiology-FMA"}]},{"project":"uniprot-human","denotations":[{"id":"T2","span":{"begin":49,"end":59},"obj":"http://www.uniprot.org/uniprot/P06280"},{"id":"T3","span":{"begin":80,"end":90},"obj":"http://www.uniprot.org/uniprot/P06280"}],"attributes":[{"subj":"T2","pred":"source","obj":"uniprot-human"},{"subj":"T3","pred":"source","obj":"uniprot-human"}]},{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T1","span":{"begin":60,"end":64},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T2","span":{"begin":60,"end":64},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"}],"attributes":[{"subj":"T1","pred":"source","obj":"GlycoBiology-NCBITAXON"},{"subj":"T2","pred":"source","obj":"GlycoBiology-NCBITAXON"}]},{"project":"EDAM-topics","denotations":[{"id":"T6","span":{"begin":16,"end":23},"obj":"http://edamontology.org/topic_0078"},{"id":"T7","span":{"begin":169,"end":176},"obj":"http://edamontology.org/topic_0634"}],"attributes":[{"subj":"T6","pred":"source","obj":"EDAM-topics"},{"subj":"T7","pred":"source","obj":"EDAM-topics"}]},{"project":"EDAM-DFO","denotations":[{"id":"T2","span":{"begin":16,"end":23},"obj":"http://edamontology.org/format_1208"},{"id":"T3","span":{"begin":16,"end":23},"obj":"http://edamontology.org/data_1467"}],"attributes":[{"subj":"T2","pred":"source","obj":"EDAM-DFO"},{"subj":"T3","pred":"source","obj":"EDAM-DFO"}]},{"project":"mondo_disease","denotations":[{"id":"T4","span":{"begin":163,"end":176},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0010526"},{"subj":"T4","pred":"source","obj":"mondo_disease"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"sentences","color":"#93ecdc","default":true},{"id":"GlycoBiology-FMA","color":"#ecc293"},{"id":"uniprot-human","color":"#a893ec"},{"id":"GlycoBiology-NCBITAXON","color":"#97ec93"},{"id":"EDAM-topics","color":"#ec93b1"},{"id":"EDAM-DFO","color":"#93cbec"},{"id":"mondo_disease","color":"#e5ec93"}]}]}}